Literature DB >> 27067334

New Ceftriaxone- and Multidrug-Resistant Neisseria gonorrhoeae Strain with a Novel Mosaic penA Gene Isolated in Japan.

Shu-Ichi Nakayama1, Ken Shimuta1, Kei-Ichi Furubayashi2, Takuya Kawahata3, Magnus Unemo4, Makoto Ohnishi5.   

Abstract

We have characterized in detail a new ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain (FC428) isolated in Japan in 2015. FC428 differed from previous ceftriaxone-resistant strains and contained a novel mosaic penA allele encoding a new mosaic penicillin-binding protein 2 (PBP 2). However, the resistance-determining 3'-terminal region of penA was almost identical to the regions of two previously reported ceftriaxone-resistant strains from Australia and Japan, indicating that both ceftriaxone-resistant strains and conserved ceftriaxone resistance-determining PBP 2 regions might spread.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27067334      PMCID： PMC4914677          DOI： 10.1128/AAC.00504-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Molecular analyses of TEM genes and their corresponding penicillinase-producing Neisseria gonorrhoeae isolates in Bangkok, Thailand.

Authors:  Shu-Ichi Nakayama; Chanwit Tribuddharat; Sasiprapa Prombhul; Ken Shimuta; Somporn Srifuengfung; Magnus Unemo; Makoto Ohnishi
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.

Authors:  M C Maiden; J A Bygraves; E Feil; G Morelli; J E Russell; R Urwin; Q Zhang; J Zhou; K Zurth; D A Caugant; I M Feavers; M Achtman; B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

3.  A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia.

Authors:  Monica M Lahra; Nathan Ryder; David M Whiley
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

4.  Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.

Authors:  Makoto Ohnishi; Daniel Golparian; Ken Shimuta; Takeshi Saika; Shinji Hoshina; Kazuhiro Iwasaku; Shu-ichi Nakayama; Jo Kitawaki; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

5.  Hybrid penicillin-binding proteins in penicillin-resistant strains of Neisseria gonorrhoeae.

Authors:  B G Spratt
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

Review 6.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Authors:  Magnus Unemo; Robert A Nicholas
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

7.  High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.

Authors:  Magnus Unemo; Daniel Golparian; Robert Nicholas; Makoto Ohnishi; Anne Gallay; Patrice Sednaoui
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

8.  Identification of amino acids conferring high-level resistance to expanded-spectrum cephalosporins in the penA gene from Neisseria gonorrhoeae strain H041.

Authors:  Joshua Tomberg; Magnus Unemo; Makoto Ohnishi; Christopher Davies; Robert A Nicholas
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

9.  Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.

Authors:  Jordi Cámara; Judit Serra; Josefina Ayats; Teresa Bastida; Dolors Carnicer-Pont; Antònia Andreu; Carmen Ardanuy
Journal:  J Antimicrob Chemother       Date:  2012-05-07       Impact factor: 5.790

10.  Mosaic-like structure of penicillin-binding protein 2 Gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime.

Authors:  Satoshi Ameyama; Shoichi Onodera; Masahiro Takahata; Shinzaburo Minami; Nobuko Maki; Katsuhisa Endo; Hirokazu Goto; Hiroo Suzuki; Yukihiko Oishi
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191
View more
  52 in total

1.  Neisseria cinerea with High Ceftriaxone MIC Is a Source of Ceftriaxone and Cefixime Resistance-Mediating penA Sequences in Neisseria gonorrhoeae.

Authors:  Gene Igawa; Yuka Yamagishi; Ken-Ichi Lee; Misato Dorin; Ken Shimuta; Hiroyuki Suematsu; Shu-Ichi Nakayama; Hiroshige Mikamo; Magnus Unemo; Makoto Ohnishi
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  First Case of Ceftriaxone-Resistant Multidrug-Resistant Neisseria gonorrhoeae in Singapore.

Authors:  Karrie Kwan Ki Ko; Martin T W Chio; Sui Sin Goh; Ai Ling Tan; Tse Hsien Koh; Nurdyana Binte Abdul Rahman
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

Review 3.  Drug-resistant Neisseria gonorrhoeae: latest developments.

Authors:  B Suay-García; M T Pérez-Gracia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-16       Impact factor: 3.267

4.  High in vitro susceptibility to the first-in-class spiropyrimidinetrione zoliflodacin among consecutive clinical Neisseria gonorrhoeae isolates from Thailand (2018) and South Africa (2015-2017).

Authors:  Susanne Jacobsson; Ranmini Kularatne; Rossaphorn Kittiyaowamarn; Venessa Maseko; Porntip Paopang; Pongsathorn Sangprasert; Pachara Sirivongrangson; Laura Piddock; Teodora Wi; Emilie Alirol; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

5.  Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.

Authors:  Jesse C Thomas; Sandra Seby; A Jeanine Abrams; Jack Cartee; Sean Lucking; Eshaw Vidyaprakash; Matthew Schmerer; Cau D Pham; Jaeyoung Hong; Elizabeth Torrone; Sancta St Cyr; William M Shafer; Kyle Bernstein; Ellen N Kersh; Kim M Gernert
Journal:  J Infect Dis       Date:  2019-06-19       Impact factor: 5.226

Review 6.  World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts.

Authors:  Magnus Unemo; Monica M Lahra; Michelle Cole; Patricia Galarza; Francis Ndowa; Irene Martin; Jo-Anne R Dillon; Pilar Ramon-Pardo; Gail Bolan; Teodora Wi
Journal:  Sex Health       Date:  2019-09       Impact factor: 2.706

7.  Typing of Neisseria Gonorrhoeae isolates in Shenzhen, China from 2014-2018 reveals the shift of genotypes associated with antimicrobial resistance.

Authors:  Yizhun Li; Yamei Li; Leshan Xiu; Yaling Zeng; Chi Zhang; Liying Sun; LuLu Zhang; Feng Wang; Junping Peng
Journal:  Antimicrob Agents Chemother       Date:  2021-02-16       Impact factor: 5.191

8.  Ceftriaxone-Resistant Neisseria gonorrhoeae Isolates (2010 to 2014) in France Characterized by Using Whole-Genome Sequencing.

Authors:  Claire de Curraize; Sylvain Kumanski; Maïté Micaëlo; Nelly Fournet; Guy La Ruche; Fabienne Meunier; Rishma Amarsy; Hervé Jacquier; Emmanuelle Cambau; Agathe Goubard; Béatrice Bercot
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

9.  A Loop-Mediated Isothermal Amplification Assay Targeting Neisseria gonorrhoeae penA-60.001.

Authors:  Ken Shimuta; Shu-Ichi Nakayama; Hideyuki Takahashi; Makoto Ohnishi
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

10.  Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.

Authors:  Alan R Katz; Alan Y Komeya; Robert D Kirkcaldy; A Christian Whelen; Olusegun O Soge; John R Papp; Ellen N Kersh; Glenn M Wasserman; Norman P O'Connor; Pamela S O'Brien; Douglas T Sato; Eloisa V Maningas; Gail Y Kunimoto; Juval E Tomas
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.